Neuspera Medical Inc.’s Post

Neuspera Medical Inc. (#LSIAlumni) closed a $23M Series D funding round led by Vertex Ventures HC and Treo Ventures. The round also had participation from Action Potential Venture Capital, Windham Venture Partners, Olympus Corporation Innovation Ventures, and another strategic investor. This round will fund the company through expected FDA premarket approval of the Neuspera System. The system is a discreet, minimally invasive, ultra-miniaturized implant designed to provide patients personal control and relief from urinary urge incontinence (UUI), a symptom of overactive bladder (OAB). It's the least invasive sacral neuromodulation device and includes an ultra-miniaturized pulse generator attached to an electrode array. The Neuspera System has FDA clearance for treating chronic pain of peripheral nerve origin and is currently an investigational device for treating UUI, a symptom associated with OAB. Congratulations to LSI Alumni, Steffen Hovard and the entire Neuspera Medical team on this major milestone! We look forward to following along your journey. Watch Steffen’s full LSI USA ‘24 presentation to learn more about Neuspera Medical - Available on our website and YouTube channel.